Enhancing immune response by targeting antigen expression
The present disclosure includes an immunogenic composition comprising an effective amount of a therapeutically engineered bacteriophage and a pharmaceutically acceptable carrier. In certain aspects, the disclosure includes methods of stimulating an immune response in a subject, comprising administer...
Gespeichert in:
Hauptverfasser: | , , , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!